PCA3 and prostate carcinoma: Importantly, the designed metal-enhanced near-infrared fluorescent satellite structure probe has been successfully used to detect PCA3 in human serum samples and prostate cancer cell lysates, demonstrating promising potential in the field of clinical cancer diagnosis.